Skip to main content

A heterometallic ruthenium–gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Heterobimetallic compounds are designed to harness chemotherapeutic traits of distinct metal species into a single molecule. The ruthenium–gold (Ru–Au) family of compounds based on Au–N-heterocyclic carbene (NHC) fragments [Cl2(p-cymene)Ru(μ-dppm)Au(NHC)]ClO4 was conceived to combine the known antiproliferative and cytotoxic properties of Au–NHC-based compounds and the antimigratory, antimetastatic, and antiangiogenic characteristic of specific Ru-based compounds. Following recent studies of the anticancer efficacies of these Ru–Au–NHC complexes with promising potential as chemotherapeutics against colorectal, and renal cancers in vitro, we report here on the mechanism of a selected compound, [Cl2(p-cymene)Ru(μ-dppm)Au(IMes)]ClO4 (RANCE-1, 1). The studies were carried out in vitro using a human clear cell renal carcinoma cell line (Caki-1). These studies indicate that bimetallic compound RANCE-1 (1) is significantly more cytotoxic than the Ru (2) or Au (3) monometallic derivatives. RANCE-1 significantly inhibits migration, invasion, and angiogenesis, which are essential for metastasis. RANCE-1 was found to disturb pericellular proteolysis by inhibiting cathepsins, and the metalloproteases MMP and ADAM which play key roles in the etiopathogenesis of cancer. RANCE-1 also inhibits the mitochondrial protein TrxR that is often overexpressed in cancer cells and facilitates apoptosis evasion. We found that while auranofin perturbed migration and invasion to similar degrees as RANCE-1 (1) in Caki-1 renal cancer cells, RANCE-1 (1) inhibited antiangiogenic formation and VEGF expression. We found that auranofin and RANCE-1 (1) have distinct proteolytic profiles. In summary, RANCE-1 constitutes a very promising candidate for further preclinical evaluations in renal cancer.

Graphical Abstract

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Abbreviations

ANCE-1:

[AuCl(IMes)]

ATCC:

American Type Culture Collection

ADAM:

A disintegrin and metalloproteinase

Auranofin:

[(2R,3R,4S,5R,6S)-3,4,5-Tris(acetyloxy)-6-{[(triethyl-λ5-phosphanylidene)aurio]sulfanyl}oxan-2-yl]methyl acetate

Caki-1:

Human clear cell renal cell carcinoma

Cisplatin:

Cis-diamminedichloroplatinum(II)

dppm:

Diphenylphosphanylmethyl(diphenyl)phosphane 

DTNB:

3,3′-Disulfanediylbis(6-nitrobenzoic acid)

HCT 116:

Human colorectal carcinoma

HUVEC:

Human umbilical vein endothelial cells

ILs:

Interleukins

IMes:

1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene

IRM90:

Human foetal lung fibroblast

MMPs:

Matrix metalloproteinase

NHC:

N-Heterocyclic carbene

p-cymene:

4-Isopropyltoluene

R:

[Ru(p-Cymene)Cl2(dppm-κP)]

RANCE-1:

[Cl2(p-Cymene)Ru(μ-dppm)Au(IMes)]ClO4

TNB2− :

5-Thio-2-nitrobenzoic acid

TrRx:

Thioredoxin reductase

VEGF:

Vascular endothelial growth factor

References

  1. Pelletier F, Comte V, Massard A, Wenzel M, Toulot S, Richard P, Picquet M, Le Gendre P, Zava O, Edafe F, Casini A, Dyson PJ (2010) J Med Chem 53:6923–6933

    Article  CAS  PubMed  Google Scholar 

  2. Liu Y, Chen TF, Wong Y-S, Mei W-J, Huang X-M, Yang F, Liu J, Zheng W-J (2010) Chem-Biol Interact 183:349–356

    Article  CAS  PubMed  Google Scholar 

  3. Wenzel M, Bertrand B, Eymin M-J, Comte V, Harvey JA, Richard P, Groessl M, Zava O, Amrouche H, Harvey PD, Le Gendre P, Picquet M, Casini A (2011) Inorg Chem 50:9472–9480

    Article  CAS  PubMed  Google Scholar 

  4. Bjelosevic H, Guzei IA, Spencer LC, Persson T, Kriel FH, Hewer R, Nell MJ, Gut J, van Resburg CEJ, Rosenthal P, Coates J, Darkwa J, Elmroth SKC (2102) J Organomet Chem 720:52–59

    Article  Google Scholar 

  5. Kaushik NK, Mishra A, Ali A, Adhikari JS, Verma AK, Gupta R (2012) J Inorg Biol Chem 17:1217–1230

    Article  CAS  Google Scholar 

  6. Nieto D, Gonzalez-Vadillo AM, Bruna S, Pastor CJ, Rios-Luci C, Leon LG, Padron JM, Navarro-Ranninger C, Cuadrado I (2012) Dalton Trans 41:432–441

    Article  CAS  PubMed  Google Scholar 

  7. Lease N, Vasileviski V, Carreira M, de Almeida A, Sanaú M, Hirva P, Casini A, Contel M (2013) J Med Chem 56:5806–5818

    Article  CAS  PubMed  Google Scholar 

  8. Garcia-Moreno E, Gascon S, Rodriguez-Yoldi MJ, Cerrada E, Laguna M (2013) Organometallics 32:3710–3720

    Article  CAS  Google Scholar 

  9. Barreiro E, Casas JS, Couce MD, Sanchez A, Sordo J, Vazquez-Lopez EM (2104) J Inorg Biochem 131:68–75

    Article  Google Scholar 

  10. Wenzel M, Bigaeva E, Richard P, Le Gendre P, Picquet M, Casini A, Bodio E (2014) J Inorg Biochem 141:10–16

    Article  CAS  PubMed  Google Scholar 

  11. Fernandez-Moreira V, Marzo I, Gimeno C (2014) Chem Sci 5:4434–4446

    Article  CAS  Google Scholar 

  12. Zaidi Y, Arjmand F, Zaidi N, Usmani JA, Zubair H, Akhatar K, Hossain M, Shadab GGHA (2014) Metallomics 6:1469–1479

    Article  CAS  PubMed  Google Scholar 

  13. Govender P, Lemmerhirt H, Hutton AT, Therrien B, Bednarski PJ, Smith GS (2014) Organometallics 33:5535–5545

    Article  CAS  Google Scholar 

  14. Bertrand B, Citta A, Franken IL, Picquet M, Folda A, Scalcon V, Rigobello MP, Le Gendre P, Casini A, Bodio E (2015) J Biol Inorg Chem 20:1005–1020

    Article  CAS  PubMed  Google Scholar 

  15. Boselli L, Carraz M, Mazeres S, Paloque L, Gonzalez G, Benoit-Vical F, Valentin A, Hemmert C, Gornitzka H (2015) Organometallics 34:1046–1055

    Article  CAS  Google Scholar 

  16. Nieto D, Bruna S, Gonzalez-Vadillo AM, Perles J, Carrillo-Hermosilla F, Antiniolo A, Padron JM, Plata GB, Cuadrado I (2015) Organometallics 34:5407–5417

    Article  CAS  Google Scholar 

  17. Nithyakumar A, Alexander V (2015) Dalton Trans 44:17800–17809

    Article  CAS  PubMed  Google Scholar 

  18. Fenton JB, Busse M, Rendina LM (2015) Aus J Chem 68:576–580

    Article  CAS  Google Scholar 

  19. Ma L, Ma R, Wang Z, Yiu S-M, Zhu G (2016) Chem Commun 52:10735–10738

    Article  CAS  Google Scholar 

  20. Singh N, Jang S, Jo J-H, Kim DH, Park DW, Kim I, Kim H, Kang SC, Chi K-W (2016) Chemistry-A Eur J 22:16157–16164

    Article  CAS  Google Scholar 

  21. Lopes J, Alves D, Morais TS, Costa PJ, Piedade M, Fatima M, Marques F, Villa de Brito MJ, Garcia MH (2017) J Inorg Biochem 169:68–78

    Article  CAS  PubMed  Google Scholar 

  22. Luengo A, Fernandez-Moreira V, Marzo I, Gimeno MC (2017) Inorg Chem 56:15159–15170

    Article  CAS  PubMed  Google Scholar 

  23. González-Pantoja JF, Stern M, Jarzecki AA, Royo E, Robles-Escajeda E, Varela-Ramirez A, Aguilera RJ, Contel M (2011) Inorg Chem 50:11099–11110

    Article  PubMed  PubMed Central  Google Scholar 

  24. Fernández-Gallardo J, Elie BT, Sulzmaier F, Sanaú M, Ramos JW, Contel M (2014) Organometallics 33:6669–6681

    Article  PubMed  PubMed Central  Google Scholar 

  25. Fernández-Gallardo J, Elie BT, Sadhukha T, Prabha S, Sanaú M, Rotenberg SA, Ramos JW, Contel M (2015) Chem Sci 6: 5269-5283. (b) Contel M, Fernández-Gallardo J, Elie BT, Ramos JW. US Patent 9,315,531 (04/19/2016)

  26. Mui YF, Fernández-Gallardo J, Gubran A, Elie BT, Maluenda I, Sanaú M, Navarro O, Contel M (2016) Organometallics 35:1218–1227

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Massai L, Fernández-Gallardo J, Guerri A, Arcangeli A, Pillozzi S, Contel M, Messori L (2015) Dalton Trans 44:11067–11076

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Fernández-Gallardo J, Elie BT, Sanaú M, Contel M (2016) Chem Commun 52:3155–3158

    Article  Google Scholar 

  29. Dean TC, Yang M, Liu M, Grayson JM, DeMartino AW, Day CS, Lee J, Furdui CM, Bierbach U (2017) ACS Med Chem Lett 8:572–576

    Article  CAS  PubMed  Google Scholar 

  30. Das S, Sinha S, Britto R, Somasundaram K, Samuelson AG (2010) J Inorg Biochem 104:93–104

    Article  CAS  PubMed  Google Scholar 

  31. Fremont P, Scott NM, Stevens ED, Nolan SP (2005) Organometallics 24:2411–2418

    Article  Google Scholar 

  32. Varghese E, Busselberg D (2014) Cancers 6:2243–2258 and refs therein

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Roder C, Thomson MJ (2015) Drugs R D 15:13–20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Adhireksan Z, Davey GE, Campomanes P, Groessl M, Clavel CM, Yu H, Nazarov AA, Yeo CHF, Ang WH, Droge P, Rothlisberger U, Dyson PJ, Davey CA (2014) Nature Comm 5:3462

    Article  Google Scholar 

  35. Nakayaa A, Sagawa M, Muto A, Uchida H, Ikedaa Y, Kizari M (2011) Leukemia Res 35:243–249

    Article  Google Scholar 

  36. Liu C, Liu Z, Li M, Li X, Wong Y-S, Ngai S-M, Zheng W, Zhang Y, Chen T (2013) PLoS ONE 8:e53945

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Fan C, Zheng W, Fu X, Li X, Wong Y-S, Chen T (2014) Cell Death and Disease 5:e191

    Google Scholar 

  38. Park S-H, Lee JH, Berek JS, Hu MC-T (2014) Int J Oncol 45:1691–1698

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Denkert C, Furstenberg A, Daniel PT, Koch I, Kobell M, Weichert W, Siegert A, Hauptmann S (2013) Oncogene 22:8653–8661

    Article  Google Scholar 

  40. Moutasim KA, Nystrom ML, Thomas GJ (2011) Methods Mol Biol 731:333–343

    Article  CAS  PubMed  Google Scholar 

  41. Hulkower KI, Herber RL (2011) Pharmaceutics 3:107–124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. DeCicco-Skinner KL, Henry GH, Cataisson C, Tabib T, Gwilliam JC, Watson NJ, Bullwinkle EM, Falkenburg L, O’Neill RC, Morin A, Wiest JS (2014) J Vis Exp 91:e51312

    Google Scholar 

  43. Cheng X, Holenya P, Can S, Alborzinia H, Rubbiani R, Ott I, Wölfl S (2014) Mol Cancer 13:221

    Article  PubMed  PubMed Central  Google Scholar 

  44. Farina AR, Tacconelli A, Cappabianca L, Masciulli MP, Holmgren A, Beckett GJ, Gulino A, Mackay AR (2001) Eur J Biochem 268:405–413

    Article  CAS  PubMed  Google Scholar 

  45. Lim HV, Hong S, Jin W, Lim S, Kim SJ, Kang HJ, Park EH, Ahn K, Lim CJ (2005) Exp Mol Med 37:497–506

    Article  CAS  PubMed  Google Scholar 

  46. Marzano C, Gandin V, Folda A, Scutari G, Bindoli A, Rigobello AP (2007) Free Radic Biol Med 42:872–881

    Article  CAS  PubMed  Google Scholar 

  47. Zou M, Zhang X, Xu C (2016) Cell Oncol 39:47–57

    Article  CAS  Google Scholar 

  48. Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN, Hsieh CY (2003) Oncogene 22:1517–1527

    Article  CAS  PubMed  Google Scholar 

  49. Suzuki M, Tetsuka T, Yoshida S, Watanabe N, Kobayashi M, Matsui N, Okamoto T (2000) FEBS Lett 465:23–27

    Article  CAS  PubMed  Google Scholar 

  50. Quail DF, Joyce JA (2013) Nat Med 19:1423–1437

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Kwong W-L, Lam K-Y, Lok C-N, Lai Y-T, Lee P-Y, Che C-M (2016) Angew Chem Int Ed 55:13524–13528

    Article  CAS  Google Scholar 

  52. Lippitz BE, Harris RA (2016) Oncoimmunology 11(5):e1093722

    Article  Google Scholar 

  53. Welte T, Zhang XH (2015) Mediators Inflamm 2015:804347. https://doi.org/10.1155/2015/804347

  54. Kim N-M, Lee M-Y, Park S-J, Choi J-S, Oh M-K (2007) Kim In-S. Immunology 122:607–614

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Li Q, Chen B, Cai J, Sun Y, Wang G, Li Y, Li R, Feng Y, Han B, Li J, Tian Y, Yi L, Jiang C (2016) PLoS ONE 11:e0151815

    Article  PubMed  PubMed Central  Google Scholar 

  56. Overall CM, Kleifeld O (2006) Nat Rev Cancer 6:227–239

    Article  CAS  PubMed  Google Scholar 

  57. He ZH, Chen N, Wang D, Bin Y, She JX (2014) Eur J Pharmacol 740:240–247

    Article  CAS  PubMed  Google Scholar 

  58. Woo JH, Lim JH, Kim YH, Suh SI, Min DS, Chang JS, Lee YH, Park JW, Kwon TK (2004) Oncogene 23:1845–1853

    Article  CAS  PubMed  Google Scholar 

  59. Woessner JF, Nagase H (2000) Matrix metalloproteinases and TIMPs: protein profile. Oxford University Press, Oxford

    Google Scholar 

  60. Rocks N, Paulissen G, El Hour M, Quesada F, Crahay C, Gueders M, Foidart JM, Noel A, Cataldo D (2008) Biochimie 90:369–379

    Article  CAS  PubMed  Google Scholar 

  61. Schlomann U, Koller G, Conrad C, Ferdous T, Golfi P, Garcia AM, Höfling S, Parsons M, Costa P, Soper R, Bossard M, Hagemann T, Roshani R, Sewald N, Ketchem RR, Moss ML, Rasmussen FH, Miller MA, Lauffenburger DA, Tuveson DA, Nimsky C, Bartsch JW (2015) Nat Commun 6:6175

    Article  PubMed  PubMed Central  Google Scholar 

  62. Yousef EM, Tahir MR, St-Pierre Y, Gaboury LA (2014) BMC Cancer 14:609

    Article  PubMed  PubMed Central  Google Scholar 

  63. Olson OC, Joyce JA (2015) Nat Rev Cancer 15:712–729

    Article  CAS  PubMed  Google Scholar 

  64. Sevenich L, Joyce JA (2014) Genes Dev 28:2331–2347

    Article  PubMed  PubMed Central  Google Scholar 

  65. Bakst RL, Xiong H, Chen CH, Deborde S, Lyubchik A, Zhou Y, He S, McNamara W, Lee SY, Olson OC, Leiner IM, Marcadis AR, Keith JW, Al-Ahmadie HA, Katabi N, Gil Z, Vakiani E, Joyce JA, Pamer E, Wong RJ (2017) Cancer Res 22:6400–6414

    Article  Google Scholar 

  66. Casini A, Gabbiani C, Sorrentino F, Rigobello MP, Bindoli A, Geldbach TJ, Marrone A, Re N, Hartinger CG, Dyson PJ, Messori L (2008) J Med Chem 51:6773–6781

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the National Cancer Institute (NCI) for grant 1SC1CA182844 (M.C.) and Dr. Karen Hubbard for providing infrastructure and advice. We are grateful to Dr. Natalia Curado and Yu-Fung Mui for their assistance in the preparation of the metallic compounds, Mike A. Cornejo for his assistance with some IC50 assays, and Ciara Bagnall for her technical expertise in imaging and immunocytochemistry.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to María Contel.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Elie, B.T., Pechenyy, Y., Uddin, F. et al. A heterometallic ruthenium–gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer. J Biol Inorg Chem 23, 399–411 (2018). https://doi.org/10.1007/s00775-018-1546-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00775-018-1546-8

Keywords

  • Bimetallic
  • Ruthenium–gold
  • Renal cancer
  • Mechanisms
  • Auranofin